These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25971867)

  • 41. Bevacizumab for the early clinical progression of diffuse intrinsic pontine glioma.
    Honda M; Fukuoka K; Tanami Y; Kurihara J; Koh K
    Pediatr Int; 2023; 65(1):e15575. PubMed ID: 37551654
    [No Abstract]   [Full Text] [Related]  

  • 42. Commentary on diffuse brain stem glioma in children.
    Brodbelt A
    Br J Neurosurg; 2008 Oct; 22(5):625. PubMed ID: 19016114
    [No Abstract]   [Full Text] [Related]  

  • 43. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
    Giussani C; Poliakov A; Ferri RT; Plawner LL; Browd SR; Shaw DW; Filardi TZ; Hoeppner C; Geyer JR; Olson JM; Douglas JG; Villavicencio EH; Ellenbogen RG; Ojemann JG
    Neuroimage; 2010 Aug; 52(1):217-23. PubMed ID: 20363335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
    Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental murine models of brainstem gliomas.
    Ni S; Chen R; Hu K
    Drug Discov Today; 2022 May; 27(5):1218-1235. PubMed ID: 34954326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
    Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
    J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming the Blood-Brain Barrier to Target Diffuse Intrinsic Pontine Glioma: What's New?
    Lu VM; Power EA; Zhang L; Daniels DJ
    World Neurosurg; 2020 Jul; 139():618-619. PubMed ID: 32389870
    [No Abstract]   [Full Text] [Related]  

  • 48. Pontine gliomas.
    Handler MH; Foreman NK
    J Neurosurg Pediatr; 2010 Jan; 5(1):140-1; author reply 141-2. PubMed ID: 20043750
    [No Abstract]   [Full Text] [Related]  

  • 49. Diffuse brainstem glioma in children: critical review of clinical trials.
    Hargrave D; Bartels U; Bouffet E
    Lancet Oncol; 2006 Mar; 7(3):241-8. PubMed ID: 16510333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma.
    Vitanza NA; Khalatbari H; Ermoian R; Sarthy J; Lockwood CM; Cole BL; Leary SES
    J Appl Lab Med; 2021 Mar; 6(2):550-553. PubMed ID: 32862234
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression.
    Oki Y; Buglio D; Zhang J; Ying Y; Zhou S; Sureda A; Ben-Yehuda D; Zinzani PL; Prince HM; Harrison SJ; Kirschbaum M; Johnston PB; Shen A; von Tresckow B; Younes A
    Blood Cancer J; 2014 Aug; 4(8):e236. PubMed ID: 25105535
    [No Abstract]   [Full Text] [Related]  

  • 52. Ring-enhancing pontine lesion in a young boy.
    Gabel BC; Levy ML; Yoon J; Crawford JR
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24038297
    [No Abstract]   [Full Text] [Related]  

  • 53. Behavioural changes caused by diffuse intrinsic pontine glioma.
    Hamamoto Filho PT; Magro IB; Zanini MA
    Rev Assoc Med Bras (1992); 2018 Jul; 64(7):581-582. PubMed ID: 30365657
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pontine glioma. Pediatric gliomas and the new World Health Organization classification of tumors of the central nervous system].
    Chico-Ponce de León F; Perezpeña-Diazconti M
    Bol Med Hosp Infant Mex; 2017; 74(2):147-153. PubMed ID: 29382498
    [No Abstract]   [Full Text] [Related]  

  • 55. Comment on: Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study.
    Perez A; Merlini L; El-Ayadi M; Korff C; Ansari M; von Bueren AO
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27664. PubMed ID: 30767367
    [No Abstract]   [Full Text] [Related]  

  • 56. Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.
    Cooney T; Lane A; Bartels U; Bouffet E; Goldman S; Leary SES; Foreman NK; Packer RJ; Broniscer A; Minturn JE; Shih CS; Chintagumpala M; Hassall T; Gottardo NG; Dholaria H; Hoffman L; Chaney B; Baugh J; Doughman R; Leach JL; Jones BV; Fouladi M; Warren KE; Monje M
    Neuro Oncol; 2017 Sep; 19(9):1279-1280. PubMed ID: 28821206
    [No Abstract]   [Full Text] [Related]  

  • 57. Angiocentric glioma of brainstem.
    Almubarak AO; Alahmari A; Al Hindi H; AlShail E
    Neurosciences (Riyadh); 2020 Oct; 25(5):416-420. PubMed ID: 33459294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Convection-enhanced delivery: chemosurgery in diffuse intrinsic pontine glioma.
    van Vuurden DG
    Lancet Oncol; 2018 Aug; 19(8):1001-1003. PubMed ID: 29914797
    [No Abstract]   [Full Text] [Related]  

  • 59. Untangling the role of mutant histone H3 in diffuse intrinsic pontine glioma.
    Creasy CL
    Nat Med; 2017 Apr; 23(4):413-414. PubMed ID: 28388610
    [No Abstract]   [Full Text] [Related]  

  • 60. Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better.
    Kieran MW
    Neuro Oncol; 2017 Aug; 19(8):1017-1018. PubMed ID: 28541486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.